Diaphorina citri psyllid: psy904


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590------
MDVDSETESNHDTALTLACAGGHEELVELLLSRGADIEHRDKKGFTPLILAATAGHDKVVDILLNHKADMEAQSERTKDTPLSLACSGGRYEVVELLLTRGANKEHRNVSDYTPLSLAASGGYVNIIKLLLTHGAEINSRTGSKLGISPLMLAAMNGHTAAVKLLLDMGSDINAQIETNRNTALTLACFQGRHEVVSLLLDRKANVEHRAKTGLTPLMEAASGGYVEVGRVLLDKGADVNAPPVPSSRDTALTIAADKGHCRFVELLLSKGAQVEVKNKKGNSPLWLAANGGHLSVVELLCKHGADIDSQDNRKVSCLMAAFRKGHVKAVRWMVNHVAQFPSDQEMTRYIQTVNDKELLDKCQECSMVIRVAKNQQAERANKNANILLEELDMEKWREESKRAAQARKRERKKQKKLEKKEEKRKAMEEEEEVIRVAKNQQAERANKNANILLEELDMEKWREESKRAAQARKRERKKQKKLEKKEEKRKAMEEEEEEEEEVEVQEVEGEMMEEETEENDMHSSGGGRGEGEEGDSGIDANSQASCSSNEVKTAAPNSRRKDKKKKKLDMRWFPCYWTGRPMWSIEPSQCLTIANN
ccccccccccccHHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHHccHHHHHHHHHcccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccccHHHHHHHcccHHHHHHHHHcccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccHHHHHHHccccHHHHHHHHHHHHHHccHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHcHHHHHHHHHHccHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
*****ETESNHDTALTLACAGGHEELVELLLSRGADIEHRDKKGFTPLILAATAGHDKVVDILLNHKADMEAQSERTKDTPLSLACSGGRYEVVELLLTRGANKEHRNVSDYTPLSLAASGGYVNIIKLLLTHGAEINSRTGSKLGISPLMLAAMNGHTAAVKLLLDMGSDINAQIETNRNTALTLACFQGRHEVVSLLLDRKANVEHRAKTGLTPLMEAASGGYVEVGRVLLDKGADVNAPPVPSSRDTALTIAADKGHCRFVELLLSKGAQVEVKNKKGNSPLWLAANGGHLSVVELLCKHGADIDSQDNRKVSCLMAAFRKGHVKAVRWMVNHVAQFPSDQEMTRYIQTVNDKELLDKCQECSMVIRVAKNQQAERANKNANILLEELDMEKWREESKRAAQARKRERKKQKKLEKKEEKRKAMEEEEEVIRVAKNQQAERANKNANILLEELDMEKWREESKR**********************************************************************************************************PCYWTGRPMWSIEPSQCLTIA**
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MDVDSETESNHDTALTLACAGGHEELVELLLSRGADIEHRDKKGFTPLILAATAGHDKVVDILLNHKADMEAQSERTKDTPLSLACSGGRYEVVELLLTRGANKEHRNVSDYTPLSLAASGGYVNIIKLLLTHGAEINSRTGSKLGISPLMLAAMNGHTAAVKLLLDMGSDINAQIETNRNTALTLACFQGRHEVVSLLLDRKANVEHRAKTGLTPLMEAASGGYVEVGRVLLDKGADVNAPPVPSSRDTALTIAADKGHCRFVELLLSKGAQVEVKNKKGNSPLWLAANGGHLSVVELLCKHGADIDSQDNRKVSCLMAAFRKGHVKAVRWMVNHVAQFPSDQEMTRYIQTVNDKELLDKCQECSMVIxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxENDMHSSGGGRGEGEEGDSGIDANSQASCSSNEVKTAAPNSRRKDKKKKKLDMRWFPCYWTGRPMWSIEPSQCLTIANN

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Ankyrin repeat and KH domain-containing protein 1 May play a role as a scaffolding protein that may be associated with the abnormal phenotype of leukemia cells. Isoform 2 may possess an antiapoptotic effect and protect cells during normal cell survival through its regulation of caspases.confidentQ8IWZ3
Ankyrin repeat and KH domain-containing protein mask Mediator of receptor tyrosine kinase (RTK) signaling, and may act either downstream of MAPK or transduce signaling through a parallel branch of the RTK pathway.confidentQ9VCA8

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0005730 [CC]nucleolusconfidentGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0005737 [CC]cytoplasmconfidentGO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:0005811 [CC]lipid particleprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0051298 [BP]centrosome duplicationprobableGO:0006996, GO:0031023, GO:0007010, GO:0051297, GO:0009987, GO:0007098, GO:0016043, GO:0008150, GO:0000226, GO:0007017, GO:0044763, GO:0044699, GO:0071840, GO:0022402, GO:0007049
GO:0001751 [BP]compound eye photoreceptor cell differentiationprobableGO:0032502, GO:0044707, GO:0030154, GO:0009653, GO:0007275, GO:0044699, GO:0001745, GO:0048869, GO:0048513, GO:0048749, GO:0009887, GO:0032501, GO:0030182, GO:0048592, GO:0009987, GO:0044767, GO:0001654, GO:0048731, GO:0001754, GO:0022008, GO:0048699, GO:0007399, GO:0007423, GO:0048856, GO:0044763, GO:0046530, GO:0008150
GO:0007492 [BP]endoderm developmentprobableGO:0032502, GO:0048856, GO:0008150, GO:0009888
GO:0008283 [BP]cell proliferationprobableGO:0008150, GO:0044699
GO:0051151 [BP]negative regulation of smooth muscle cell differentiationprobableGO:0051093, GO:0050793, GO:0045595, GO:0050794, GO:0008150, GO:0045596, GO:0051150, GO:0065007, GO:0051147, GO:0048519, GO:0051148, GO:0050789, GO:0048523
GO:0006464 [BP]cellular protein modification processprobableGO:0044267, GO:0044260, GO:0044238, GO:0019538, GO:0009987, GO:0044237, GO:0043170, GO:0071704, GO:0043412, GO:0036211, GO:0008150, GO:0008152
GO:0007169 [BP]transmembrane receptor protein tyrosine kinase signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699
GO:0005515 [MF]protein bindingprobableGO:0003674, GO:0005488
GO:0044459 [CC]plasma membrane partprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425
GO:0019730 [BP]antimicrobial humoral responseprobableGO:0009607, GO:0050896, GO:0002376, GO:0008150, GO:0006955, GO:0006959, GO:0051707, GO:0051704
GO:0030054 [CC]cell junctionprobableGO:0005575
GO:0005856 [CC]cytoskeletonprobableGO:0043232, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0043228, GO:0044424, GO:0043226
GO:0003824 [MF]catalytic activityprobableGO:0003674
GO:0060047 [BP]heart contractionprobableGO:0032501, GO:0044707, GO:0008015, GO:0003013, GO:0008150, GO:0003015, GO:0044699, GO:0003008
GO:0001955 [BP]blood vessel maturationprobableGO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0044699, GO:0048731, GO:0010259, GO:0007275, GO:0071695
GO:0046427 [BP]positive regulation of JAK-STAT cascadeprobableGO:0023051, GO:0046425, GO:0009966, GO:0010740, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0009967, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0010627, GO:0050789, GO:0048522
GO:0051641 [BP]cellular localizationprobableGO:0008150, GO:0009987, GO:0044763, GO:0051179, GO:0044699
GO:0042383 [CC]sarcolemmaprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886
GO:0033267 [CC]axon partprobableGO:0044463, GO:0044464, GO:0005623, GO:0030424, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0003723 [MF]RNA bindingprobableGO:0097159, GO:0003674, GO:1901363, GO:0003676, GO:0005488

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 1N11, chain A
Confidence level:very confident
Coverage over the Query: 12-341
View the alignment between query and template
View the model in PyMOL
Template: 1OT8, chain A
Confidence level:probable
Coverage over the Query: 159-358
View the alignment between query and template
View the model in PyMOL
Template: 2ZUO, chain A
Confidence level:probable
Coverage over the Query: 297-338,352-518
View the alignment between query and template
View the model in PyMOL
Template: 3NZJ, chain F
Confidence level:probable
Coverage over the Query: 417-437,449-498
View the alignment between query and template
View the model in PyMOL